Christian Loesche

This inventor holds 12 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Galderma Laboratories Inc., Galderma Research & Development, Galderma Research & Development Snc. Active years: 2011-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Loesche. Retrieved from https://idiyas.com/inventor/christian-loesche

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 9)

% Patents Active = 83.3

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 45(Granted Patents)

Location History:

Valbonne, FR (2011 - 2014)
Hegenheim, FR (2018)

Company Filing History:

6 out of 27

Galderma Laboratories Inc.

patents

5 out of 222

Galderma Research & Development

patents

1 out of 29

Galderma Research & Development Snc

patents

Years Active: 2011-2018

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9861632 - Methods and compositions for safe and effective treatment of erythema (2018-01-09),

2. 9861631 - Methods and compositions for safe and effective treatment of erythema (2018-01-09),

3. 8916562 - Methods and compositions for safe and effective treatment of telangiectasia (2014-12-23),

4. 8785420 - Combination/association of adapalene and benzoyl peroxide for treating acne lesions (2014-07-22),

5. 8586586 - Methods and compositions for treating or preventing erythema (2013-11-19),

6. 8513249 - Methods and compositions for safe and effective treatment of erythema (2013-08-20),

7. 8513247 - Methods and compositions for safe and effective treatment of erythema (2013-08-20),

8. 8445543 - Combinations of adapalene and benzoyl peroxide for treating acne lesions (2013-05-21),

9. 8410102 - Methods and compositions for treating or preventing erythema (2013-04-02),

10. 8129362 - Combination/association of adapalene and benzoyl peroxide for treating acne lesions (2012-03-06),

11. 8080537 - Combinations of adapalene and benzoyl peroxide for treating acne lesions (2011-12-20),

12. 8071644 - Combinations of adapalene and benzoyl peroxide for treating acne lesions (2011-12-06),

Title: Innovations by Christian Loesche: Pioneering Treatments for Erythema

Introduction

Christian Loesche is an esteemed inventor based in Valbonne, France, known for his significant contributions to dermatological treatments. With a total of 12 granted patents, his work focuses primarily on safe and effective methods for treating erythema, a common skin condition that causes redness and inflammation.

Latest Patents

Among his latest patents are breakthrough methods and compositions aimed at treating erythema. These innovations involve the topical application of a specially formulated composition that includes approximately 0.3% to 10% by weight of brimonidine along with a pharmaceutically acceptable carrier. This formulation is designed to provide effective relief for those suffering from symptoms associated with erythema.

Career Highlights

Christian has collaborated with prestigious companies such as Galderma Laboratories Inc. and Galderma Research & Development. His work in these organizations has contributed to the advancement of dermatological solutions, highlighting his expertise in the field.

Collaborations

Throughout his career, Christian has worked alongside notable colleagues, including Michael Graeber and Philip Freidenreich. Their teamwork has sparked innovative ideas and propelled the development of new treatments within the industry.

Conclusion

Christian Loesche's dedication to innovation in skincare exemplifies the impactful role inventors play in enhancing medical treatments. With a promising catalog of patents and a strong professional background, he continues to lead advancements in the effective management of conditions like erythema, ensuring better outcomes for patients.

Profile summary based on public USPTO records.